200 related articles for article (PubMed ID: 11926854)
1. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction.
Yarzebski J; Bujor CF; Goldberg RJ; Spencer F; Lessard D; Gore JM
Arch Intern Med; 2002 Apr; 162(7):797-804. PubMed ID: 11926854
[TBL] [Abstract][Full Text] [Related]
2. Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
Krempf M; Simpson RJ; Ramey DR; Brudi P; Giezek H; Tomassini JE; Lee R; Farnier M
Lipids Health Dis; 2015 May; 14():45. PubMed ID: 25985907
[TBL] [Abstract][Full Text] [Related]
3. Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study.
Berger AK; Duval SJ; Armstrong C; Jacobs DR; Luepker RV
Am J Geriatr Cardiol; 2007; 16(1):15-23. PubMed ID: 17215638
[TBL] [Abstract][Full Text] [Related]
4. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
Simonyi G
Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
[TBL] [Abstract][Full Text] [Related]
5. Lipid attainment among patients newly treated with lipid-altering drugs.
Hess G; Chang CL; Chung K
Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol testing and management: a national comparison of family physicians, general internists, and cardiologists.
Eaton CB; Monroe A; McQuade W; Eimer MJ
J Am Board Fam Pract; 1998; 11(3):180-6. PubMed ID: 9625508
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease.
Mendelson G; Aronow WS
J Am Geriatr Soc; 1998 Sep; 46(9):1128-31. PubMed ID: 9736107
[TBL] [Abstract][Full Text] [Related]
8. Attitude changes of general practitioners towards lowering LDL cholesterol.
Strandberg TE; Pitkänen A; Larjo P; Hirvonen P; Kohvakka A
J Cardiovasc Risk; 1998 Feb; 5(1):43-6. PubMed ID: 9816555
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol treatment practices of primary care physicians.
Hyman DJ; Maibach EW; Flora JA; Fortmann SP
Public Health Rep; 1992; 107(4):441-8. PubMed ID: 1641441
[TBL] [Abstract][Full Text] [Related]
10. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients.
Bruckert E; Pouchain D; Auboiron S; Mulet C
Arch Cardiovasc Dis; 2012 Nov; 105(11):557-65. PubMed ID: 23177484
[TBL] [Abstract][Full Text] [Related]
11. Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.
Yarzebski J; Granillo E; Spencer FA; Lessard D; Gurwitz JH; Gore JM; Goldberg RJ
Int J Cardiol; 2009 Feb; 132(1):66-74. PubMed ID: 18201781
[TBL] [Abstract][Full Text] [Related]
12. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
Aronow WS; Ahn C
Am J Cardiol; 2002 Jan; 89(1):67-9. PubMed ID: 11779527
[No Abstract] [Full Text] [Related]
13. CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.
Raal F; Schamroth C; Blom D; Marx J; Rajput M; Haus M; Hussain R; Cassim F; Nortjé M; Vandehoven G; Temmerman AM
Cardiovasc J Afr; 2011; 22(5):234-40. PubMed ID: 21922121
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
[TBL] [Abstract][Full Text] [Related]
15. [Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels].
Laufs U
Dtsch Med Wochenschr; 2012 Oct; 137(43):2200. PubMed ID: 23076665
[No Abstract] [Full Text] [Related]
16. Degree of Lipid Control in Patients With Coronary Heart Disease and Measures Adopted by Physicians. REPAR Study.
Galve E; Cordero A; Cequier A; Ruiz E; González-Juanatey JR
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):931-938. PubMed ID: 27178117
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol > 125 mg/dl.
Aronow WS
Am J Cardiol; 1998 Sep; 82(5):668-9, A6, A8. PubMed ID: 9732899
[TBL] [Abstract][Full Text] [Related]
18. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends (1986-1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction: a population-based perspective.
Yarzebski J; Spencer F; Goldberg RJ; Lessard D; Gore JM
Arch Intern Med; 2001 Jun; 161(12):1521-8. PubMed ID: 11427100
[TBL] [Abstract][Full Text] [Related]
20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
